GlassScriptPhysician profile
Aimee Adams
NPI 1023561214
$2,572.42
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,436 · 2022: $136.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $498.63 | 2021 | |
| Esperion Therapeutics, INC. | $397.84 | 2021 | |
| Abbvie INC. | $217.95 | 2021 | |
| Amarin Pharma, INC. | $205.55 | 2021 | |
| Corcept Therapeutics | $182.61 | 2021 | |
| Horizon Therapeutics Plc | $127.97 | 2021 | |
| Lilly USA, LLC | $106.08 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $101.26 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.18 | 2021 | |
| Amgen INC. | $89.91 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $81.87 | 2021 | |
| Janssen Pharmaceuticals, INC | $77.60 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.35 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $70.02 | 2021-2022 | |
| Csl Behring | $60.32 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $40.06 | 2021 | |
| Dexcom, INC. | $33.69 | 2021 | |
| Astellas Pharma US INC | $31.49 | 2021 | |
| Eisai INC. | $17.31 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $17.21 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.70 | 2022 | |
| Bioventus LLC | $12.82 | 2022 | |
| Merck Sharp & Dohme LLC | $11.63 | 2021 | |
| Genentech USA, INC. | $1.37 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.